Page last updated: 2024-08-16

resorcinol and 2,4-diaminopyrimidine

resorcinol has been researched along with 2,4-diaminopyrimidine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, J; Geng, K; Geng, M; Liu, H; Shen, A; Song, Z; Yang, H; Zhang, A; Zhang, C; Zhang, M	1

Other Studies

1 other study(ies) available for resorcinol and 2,4-diaminopyrimidine

Article	Year
Design, synthesis and pharmacological evaluation of ALK and Hsp90 dual inhibitors bearing resorcinol and 2,4-diaminopyrimidine motifs. European journal of medicinal chemistry, 2018, May-25, Volume: 152 Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; HSP90 Heat-Shock Proteins; Humans; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Receptor Protein-Tyrosine Kinases; Resorcinols; Structure-Activity Relationship	2018

Article

Year

Design, synthesis and pharmacological evaluation of ALK and Hsp90 dual inhibitors bearing resorcinol and 2,4-diaminopyrimidine motifs.

European journal of medicinal chemistry, 2018, May-25, Volume: 152

Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; HSP90 Heat-Shock Proteins; Humans; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Receptor Protein-Tyrosine Kinases; Resorcinols; Structure-Activity Relationship

2018